Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Genentech Inc.
Current Parent Company: Roche
Parent at the Time of the Penalty Announcement:  subscribe to see this data field
Penalty: $19,000,000
Year: 2000
Date: January 27, 2000
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Secondary Offense: False Claims Act and related
Violation Description: Genentech paid $19 million to state Medicaid programs as part of a $50 million civil and criminal settlement with the federal government of allegations that the company promoted Protropin, a human growth hormone, for uses that had not been approved by the Food and Drug Administration.
Level of Government: state
Action Type: agency action
Agency: Multistate Attorneys General Case
Civil or Criminal Case: civil
HQ Country of Current Parent: Switzerland
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.